[为慢性髓性白血病选择一线治疗的关键点]
1Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University.
概括
慢性髓性白血病 (CML) 的治疗包括根据个体患者的因素选择最佳的氨酸激酶抑制剂 (TKI). 目标是转向无治疗缓解 (TFR) 和潜在的治愈.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性髓性白血病 (CML) 是由BCR::ABL1融合基因驱动的.
- 氨酸激酶抑制剂 (TKIs) 已经彻底改变了CML治疗,显著改善了生存率.
- 在日本,有5种技术知识产权被批准用于一线治疗,每种技术知识产权都有独特的特征.
研究的目的:
- 审查当前证据和选择慢性阶段CML的第一线TKI治疗的实际考虑.
- 讨论优化长期结果,并向个性化治疗策略迈进.
- 探索新兴目标,如无治疗缓解 (TFR) 和潜在的治疗方法.
主要方法:
- 审查当前的临床试验数据和证据,第一线TKIs在CML.
- 对已批准药物的不同疗效和毒性概况的分析.
- 考虑影响治疗决策的患者特定因素.
主要成果:
- 个性化治疗选择至关重要,考虑到年龄,并发症,心血管风险,生育能力,坚持和财务因素.
- 治疗目标正在从疾病控制发展到实现无治疗缓解 (TFR).
- 低剂量和阶段性TKI疗法旨在平衡疗效与耐受性和生活质量.
结论:
- 优化一线TKI选择是长期CML管理的关键.
- 未来的方向包括探索TFR的免疫学决定因素和针对潜在治疗的新型干细胞向疗法.
- 个性化医疗方法正在推进CML治疗,以改善结果和缓解.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.7K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.8K
相关概念视频
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:21Stem Cell Therapy for Tissue Regeneration
4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
01:15Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
01:21Lineage Commitment
4.5K
Commitment is the process whereby stem cells:
4.5K